In this interview from the Video Journal of Biomedicine, Hannah Brown (Ipsos Healthcare, London, UK) discusses physician and patient treatment decision-making for relapsing–remitting multiple sclerosis.
Take a look behind the scenes of a study published in Brain, as we ask Dr Ryan D’Arcy about the establishment of brain vital signs for concussion-related impairments.
Discover more about an ongoing, multicenter registry that provides real-world evidence regarding ataluren use in nonsense mutation Duchenne muscular dystrophy patients in this research article.
In this Editorial, published in the journal Future Neurology, the author discusses the need for continued funding for spinal muscular atrophy.
In this review article, published in the journal Immunotherapy, the authors explore immunotherapy for neuroblastoma from therapeutic backbone to the latest discoveries.
Take a look behind the scenes of a recent paper in Biomarkers in Medicine as we ask the author about oligomeric α-synuclein in basal tears of Parkinson’s patients.
In this Editorial published in Immunotherapy, researchers explore the use of antibodies directed against amyloid-β oligomers for Alzheimer’s disease.
What is the optimal treatment for Duchenne muscular dystrophy in the MENA region? Find out in this paper published by Neurodegenerative Disease Management.
Whilst at the ARUK Conference 2019, we had the pleasure of speaking with Hugh Perry about neuroinflammation and Alzheimer’s disease, particularly the role of microglia in brain homeostasis.
Jenny Straiton explores the miniature world of organoids and discusses how these small models are making big changes in the world of neurological research.
